Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European Countries
Open Access
- 1 August 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (2) , 444-450
- https://doi.org/10.1086/313977
Abstract
Pneumococcal vaccination of older persons is thought to be cost-effective in preventing pneumococcal pneumonia, but evidence of clinical protection iKeywords
This publication has 26 references indexed in Scilit:
- Costes de las inoculaciones accidentales en personal sanitario de un hospitalGaceta Sanitaria, 1998
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyThe American Journal of Medicine, 1997
- Pneumococcal Vaccination: Four Issues for Western EuropeBiologicals, 1997
- Cost-effectiveness of vaccination against pneumococcal pneumonia in The NetherlandsEuropean Journal of Public Health, 1997
- Pneumococcal Vaccine After 15 Years of UseArchives of internal medicine (1960), 1994
- Pneumococcal Polysaccharide Vaccine EfficacyJAMA, 1993
- Issues in the Cross-National Assessment of Health TechnologyInternational Journal of Technology Assessment in Health Care, 1992
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991
- Review of Recent Pneumococcal Infections with Attention to Vaccine and Nonvaccine SerotypesClinical Infectious Diseases, 1990
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986